Comment on: "One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients" by Boschetti et al

Endocrine. 2017 Feb;55(2):653-654. doi: 10.1007/s12020-016-1024-4. Epub 2016 Jul 8.

Authors

Lorenzo Curtò¹, Cesare de Gregorio²

Affiliations

¹ Department of Clinical and Experimental Medicine, Endocrinology Unit, University of Messina, AOU Policlinico "G. Martino" (Block H, floor 4), Via Consolare Valeria, 1, Messina, 98125, Italy. curto.loren@libero.it.
² Department of Clinical and Experimental Medicine, Cardiology Unit, University of Messina, Messina, Italy.

PMID: 27393300
DOI: 10.1007/s12020-016-1024-4

No abstract available

Publication types

Letter
Comment

MeSH terms

Adult
Growth Hormone
Heart*
Hormone Replacement Therapy
Human Growth Hormone*
Humans
Insulin-Like Growth Factor I

Substances

Human Growth Hormone
Insulin-Like Growth Factor I
Growth Hormone